FDA

IF Copack LLC, operating as Initiative Foods, announced a voluntary recall Friday of Tippy Toes Apple Pear Banana fruit puree after federal testing revealed excessive patulin contamination. FDA Study Detects Mycotoxin Contamination The U.S. Food and Drug Administration found toxic levels of patulin...

Novo Nordisk A/S (NYSE:NVO) is trading higher on Friday after falling for two consecutive days on lower-than-expected fiscal 2026 guidance and compounding concerns. • Novo Nordisk stock is showing exceptional strength. What’s behind NVO gains? On Tuesday, the company said it expects...

Philip Morris International Inc. (NYSE:PM) shares were trading slightly higher Friday after the company urged a key U.S. regulator to back a modified-risk label for its ZYN nicotine pouches. • Philip Morris Intl shares are advancing steadily. Why is PM stock advancing? Philip Morris...

Major U.S. stock indices closed higher Tuesday, with the Dow Jones Industrial Average up 0.16% at 48,442.41, the S&P 500 advancing 0.46% to 6,909.79, and the Nasdaq climbing 0.57% to 23,561.84. These are the top stocks that gained the attention of retail traders and investors through the day....

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock jumped on Friday after the FDA issued a new boxed warning for Elevidys. The updated approval follows recent reports of fatal liver injury in non-ambulatory pediatric patients who received the gene therapy.  SRPT stock is moving. Watch the price...

The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson & Johnson’s (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer. Darzalex Faspro is the first and only approved treatment for high-risk smoldering multiple myeloma (HR-SMM),...

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless...

President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs. Trump Demands Drug Firms Reveal COVID Vaccine Data Trump took to his social media platform, Truth Social, on Monday and called on drug companies to ‘...

On Monday, Palantir Technologies Inc. (NASDAQ:PLTR) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration, warning that bureaucratic inertia is putting the U.S. behind China in the biotech race. What Happened: In a blog post, Lonsdale said the FDA's current...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who is making strides in his war against synthetic food dyes, is now targeting colorful favorites such as Jell-O snacks, Kool-Aid and Lucky Charms cereals. By the end of 2027, many of these products are meant to be free of...

The U.S. Food and Drug Administration (FDA) on Wednesday initiated an immediate review of clinical trials that involved sending Americans’ living cells to China and other foreign adversaries for genetic engineering and subsequent infusion back into U.S. patients, sometimes without their...

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) for adult patients with bullous pemphigoid (BP), a rare, chronic autoimmune skin disorder. BP primarily affects elderly...

The U.S. Food and Drug Administration (FDA) announced its Commissioner's National Priority Voucher (CNPV) program. What Happened: The FDA aims to modernize its regulatory framework to meet emerging public health needs. Drug developers may redeem the new voucher to participate in the FDA’s...

The U.S. Food and Drug Administration (FDA) expanded approval of Moderna Inc.’s (NASDAQ:MRNA) respiratory syncytial virus vaccine to adults aged 18-59 at increased risk for disease. What Happened: The FDA on Thursday approved broader use of Moderna’s mRESVIA vaccine for younger at-risk...

The American Pharmacists Association announced Monday it will withhold endorsement of the Centers for Disease Control and Prevention’s updated immunization schedule that removed COVID-19 vaccine recommendations for pregnant women and healthy children. What Happened: The CDC modified its...